Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
1.530
-0.030 (-1.92%)
At close: Jun 17, 2026, 4:00 PM EDT
1.500
-0.030 (-1.96%)
After-hours: Jun 17, 2026, 6:56 PM EDT
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $283.48 million as of June 17, 2026. Its market cap has increased by 135.85% in one year.
Market Cap
283.48M
Enterprise Value
189.79M
1-Year Change
135.85%
Ranking
Category
Stock Price
$1.53
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $283.48M, a decrease of -89.03%. That is a compound annual growth rate of -55.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 283.48M | -6.81% |
| Dec 31, 2025 | 304.19M | -82.24% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
| Sep 15, 2023 | 2.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atrium Therapeutics | 213.14M |
| Q32 Bio | 211.62M |
| Coherus Oncology | 209.78M |
| Minerva Neurosciences | 209.65M |
| Cybin | 207.65M |
| LENZ Therapeutics | 206.63M |
| Arcturus Therapeutics Holdings | 204.08M |
| ALX Oncology Holdings | 203.19M |